共 212 条
[1]
Ryder S(2017)The burden, epidemiology, costs and treatment for Duchenne muscular dystrophy: an evidence review Orphanet J Rare Dis 12 79-928
[2]
Leadley RM(1987)Dystrophin: the protein product of the Duchenne muscular dystrophy locus Cell 51 919-262
[3]
Armstrong N(1989)Association of dystrophin and an integral membrane glycoprotein Nature 338 259-3714
[4]
Westwood M(1993)Dystrophin protects the sarcolemma from stresses developed during muscle contraction Proc Natl Acad Sci U S A 90 3710-306
[5]
de Kock S(2015)Interactions between muscle stem cells, mesenchymal-derived cells and immune cells in muscle homeostasis, regeneration and disease Cell Death Dis 6 e1830-277
[6]
Butt T(2017)Clinical outcomes in Duchenne muscular dystrophy: a study of 5345 patients from the TREAT-NMD DMD global database J Neuromuscul Dis 4 293-117
[7]
Hoffman EP(1990)The incidence and evolution of cardiomyopathy in Duchenne muscular dystrophy Int J Cardiol 26 271-319
[8]
Brown RH(2007)Dystrophin, its interactions with other proteins, and implications for muscular dystrophy Biochim Biophys Acta 1772 108-752
[9]
Kunkel LM(1990)Deficiency of a glycoprotein component of the dystrophin complex in dystrophic muscle Nature 345 315-508
[10]
Campbell KP(1990)Glycoprotein complex anchoring dystrophin to sarcolemma J Biochem 108 748-9165